Cargando…
Regional radiotherapy versus an axillary lymph node dissection after lumpectomy: a safe alternative for an axillary lymph node dissection in a clinically uninvolved axilla in breast cancer. A case control study with 10 years follow up
BACKGROUND: The standard treatment of the axilla in breast cancer used to be an axillary lymph node dissection. An axillary lymph node dissection is known to give substantial risks of morbidity. In recent years the sentinel node biopsy has become common practice. Future randomized study results will...
Autores principales: | Spruit, Patty H, Siesling, Sabine, Elferink, Marloes AG, Vonk, Ernest JA, Hoekstra, Carel JM |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2173900/ https://www.ncbi.nlm.nih.gov/pubmed/17971196 http://dx.doi.org/10.1186/1748-717X-2-40 |
Ejemplares similares
-
Axillary lymph node dissection on the run?
por: Maeseele, N, et al.
Publicado: (2017) -
Axillary lymph node dissection: Dead or still alive?
por: Beck, Anna C., et al.
Publicado: (2023) -
Radiotherapy instead of axillary lymph node dissection: evaluation of axillary lymph node dose coverage with whole breast radiotherapy
por: Bukovszky, Bence, et al.
Publicado: (2022) -
Can targeted axillary dissection reliably advise de-escalation of completion axillary lymph node dissection?
por: Owusu-Brackett, Nicci, et al.
Publicado: (2023) -
Is Pathologic Axillary Staging Valid If Lymph Nodes Are Less than 10 with Axillary Lymph Node Dissection after Neoadjuvant Chemotherapy?
por: Choi, Hee Jun, et al.
Publicado: (2022)